Nadine Tung MD, MPH

Nadine Tung, MD is the Director of the Cancer Genetics and Prevention Program at Beth Israel Deaconess Medical Center (BIDMC), which she established in 1997 to evaluate patients and families with hereditary cancer syndromes. She is also a breast medical oncologist and a member of the Dana-Farber Harvard Cancer Center as well as a Professor of Medicine at Harvard Medical School. She graduated from Princeton University in 1980 and Harvard Medical School in 1984.

Dr. Tung’s research focuses on hereditary causes of breast cancer as well as effective strategies for breast cancer prevention and treatment. Much of her research has focused on women with BRCA1 and BRCA2 mutations, studying the genetic and environmental factors that influence cancer development as well as the biology and prognosis of the breast cancers they develop. Dr. Tung was recently elected as a Fellow of the American Society of Clinical Oncology (ASCO).